Bio-Rad Laboratories, Inc.
$238.18
Stock Quotes & Analysis
2.87%
$238.18
Latest AAPL News (Need to figure out how to make this dynamic)
Graphene is an excellent conductor of electricity and heat, surpassing traditional materials like silicon, and…
The ballots have been counted, the speeches have been made, and the confetti has settled.…
The political winds are shifting, and Wall Street is taking notice. As Donald Trump’s approval…
In the shadows of Silicon Valley’s AI frenzy, a sleeping giant is awakening. While tech…
Status: Active
Sector: Healthcare
Industry: Medical Devices
Symbol: BIO
Exchange: NYQ
Employees: 7700
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
1000 Alfred Nobel Drive, Hercules, CA, United States | |
510 724 7000 | |
https://www.bio-rad.com |